Delivery Order SPE2DB22D2206-SPE2DB25FGE24
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ropinirole HCL ER 12 mg tablets, with a ceiling value of $1,536.03 and a completion date of January 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of Ropinirole HCL ER 6 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,555.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,406.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ropinirole HCL ER 6 mg Tablets in 30-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of October 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is supplying these essential medications to support military treatment facilities and other government healthcare programs. The contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,135.79, is for the delivery of ropinirole HCL ER 6 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,314.25 firm fixed-price contract is for the delivery of ROPINIROLE HCL ER 8 MG tablets, a medication used to treat Parkinson's disease and restless leg syndrome. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,745.89, is for the delivery of 500 tablets of the prescription medication Ropinirole Hydrochloride 1 mg. This is a firm fixed-price delivery order contract with a completion date of November 17, 2023. The contract was awarded on November 16, 2023 and was not designated as a set-aside procurement. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $13,929.10 with a firm fixed price pricing type and a completion date of January 21, 2025. The contract provides pharmaceutical products, including the ORSERDU 345 MG TABLET 30S, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,256.57 with a completion date of July 22, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the procurement of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,035.66 firm fixed-price delivery order is for 4564898835 REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $12,570.22, is for the delivery of pharmaceutical products including medications, medical supplies, and devices. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...